Hyperfine (HYPR) Free Cash Flow (2021 - 2026)
Hyperfine (HYPR) posted Free Cash Flow of -$9.1 million for Q1 2026, down 72.24% on a QoQ basis from -$5.3 million in Q4 2025, and little changed year-over-year from -$9.0 million in Q1 2025.
Hyperfine (HYPR) Free Cash Flow (2021 - 2026) Analysis & Trends
Hyperfine's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$9.1 million for Q1 2026.
- Quarterly Free Cash Flow changed 0.48% year-over-year to -$9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.1 million (up 15.22% YoY) and the FY2025 annual result came in at -$29.1 million, up 24.22% from the prior year.
- Free Cash Flow was -$9.1 million for Q1 2026 at Hyperfine, down from -$5.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$5.3 million in Q4 2025 and bottomed at -$27.4 million in Q1 2022.
- A 5-year average of -$11.3 million and a median of -$9.4 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 262.55% — and 2023, when it soared 50.54%.
- Hyperfine's Free Cash Flow stood at -$15.6 million in 2022, then soared by 33.76% to -$10.3 million in 2023, then grew by 27.56% to -$7.5 million in 2024, then climbed by 29.37% to -$5.3 million in 2025, then plunged by 72.24% to -$9.1 million in 2026.
- Business Quant data shows HYPR's Free Cash Flow at -$9.1 million in Q1 2026, -$5.3 million in Q4 2025, and -$5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | -9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08 Mn |
| Mar 31, 2026 | -9.08 Mn |
| Dec 31, 2025 | -5.27 Mn |
| Dec 31, 2025 | -5.27 Mn |
| Sep 30, 2025 | -5.71 Mn |
| Sep 30, 2025 | -5.71 Mn |
| Jun 30, 2025 | -9.03 Mn |
| Jun 30, 2025 | -9.03 Mn |
| Mar 31, 2025 | -9.12 Mn |
| Mar 31, 2025 | -9.12 Mn |
| Dec 31, 2024 | -7.46 Mn |
| Dec 31, 2024 | -7.46 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Sep 30, 2024 | -8.35 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -13.25 Mn |
| Mar 31, 2024 | -13.25 Mn |
| Dec 31, 2023 | -10.30 Mn |
| Dec 31, 2023 | -10.30 Mn |